Rituximab on lung, skin, and joint involvement in patients with systemic sclerosis: A case series study and review of the literature.

Yarkan Tugsal, Handan; Zengin, Berrin; Kenar, Gökçe; Önen, Fatos; Birlik, Merih

Yarkan Tugsal, Handan; Zengin, Berrin; Kenar, Gökçe; Önen, Fatos; Birlik, Merih.

Afiliación

Yarkan Tugsal H; Department of Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
Zengin B; Department of Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
Kenar G; Department of Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
Önen F; Department of Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
Birlik M; Department of Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey.

Int J Rheum Dis ; 25(7): 755-768, 2022 Jul.

Article en En | MEDLINE | ID: mdl-35535670

Asunto(s)

Artritis; Enfermedades Pulmonares Intersticiales; Esclerodermia Sistémica; Humanos; Pulmón; Persona de Mediana Edad; Rituximab/efectos adversos; Esclerodermia Sistémica/complicaciones; Esclerodermia Sistémica/diagnóstico; Esclerodermia Sistémica/tratamiento farmacológico; Piel; Resultado del Tratamiento

Palabras clave

anti-CD20; review; rituximab; scleroderma; systemic sclerosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis / Esclerodermia Sistémica / Enfermedades Pulmonares Intersticiales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans / Middle aged Idioma: En Revista: Int J Rheum Dis Asunto de la revista: REUMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google